docetaxel anhydrous has been researched along with 2-chloroadenosine in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (2-chloroadenosine) | Trials (2-chloroadenosine) | Recent Studies (post-2010) (2-chloroadenosine) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 889 | 13 | 47 |
| Protein | Taxonomy | docetaxel anhydrous (IC50) | 2-chloroadenosine (IC50) |
|---|---|---|---|
| high affinity choline transporter 1 isoform a | Homo sapiens (human) | 0.5377 | |
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.037 | |
| Adenosine receptor A2b | Rattus norvegicus (Norway rat) | 0.16 | |
| Adenosine receptor A2a | Rattus norvegicus (Norway rat) | 0.16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellezza, I; Bracarda, S; Conte, C; Culig, Z; Minelli, A; Tucci, A | 1 |
1 other study(ies) available for docetaxel anhydrous and 2-chloroadenosine
| Article | Year |
|---|---|
2-chloroadenosine modulates PAR-1 and IL-23 expression and enhances docetaxel effects on PC3 cells.
Topics: 2-Chloroadenosine; Agar; Antineoplastic Agents; Apoptosis; Cell Division; Cell Line, Tumor; Docetaxel; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Interleukin-23 Subunit p19; Male; Prostatic Neoplasms; Receptor, PAR-1; S Phase; Stem Cells; Taxoids | 2008 |